NO20023526L - Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes - Google Patents

Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes

Info

Publication number
NO20023526L
NO20023526L NO20023526A NO20023526A NO20023526L NO 20023526 L NO20023526 L NO 20023526L NO 20023526 A NO20023526 A NO 20023526A NO 20023526 A NO20023526 A NO 20023526A NO 20023526 L NO20023526 L NO 20023526L
Authority
NO
Norway
Prior art keywords
diabetes
preparation
treatment
methods
vascular disease
Prior art date
Application number
NO20023526A
Other languages
English (en)
Other versions
NO20023526D0 (no
Inventor
Howard Yoshihisa Ando
Donald Eugene Butler
Gary Jay Dozeman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20023526D0 publication Critical patent/NO20023526D0/no
Publication of NO20023526L publication Critical patent/NO20023526L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20023526A 2000-01-25 2002-07-24 Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes NO20023526L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25
PCT/IB2001/000026 WO2001055078A1 (en) 2000-01-25 2001-01-11 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith

Publications (2)

Publication Number Publication Date
NO20023526D0 NO20023526D0 (no) 2002-07-24
NO20023526L true NO20023526L (no) 2002-08-27

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023526A NO20023526L (no) 2000-01-25 2002-07-24 Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes

Country Status (39)

Country Link
EP (1) EP1259474B1 (no)
JP (1) JP4750995B2 (no)
KR (1) KR20020073182A (no)
CN (1) CN1395555A (no)
AP (1) AP2002002587A0 (no)
AR (1) AR029436A1 (no)
AT (1) ATE431326T1 (no)
AU (1) AU2214001A (no)
BG (1) BG106851A (no)
BR (1) BR0107763A (no)
CA (1) CA2397960C (no)
CO (1) CO5261537A1 (no)
CZ (1) CZ20022474A3 (no)
DE (1) DE60138686D1 (no)
DK (1) DK1259474T3 (no)
DZ (1) DZ3239A1 (no)
EA (1) EA004862B1 (no)
EE (1) EE200200404A (no)
ES (1) ES2324281T3 (no)
GE (1) GEP20053428B (no)
GT (1) GT200100015A (no)
HN (1) HN2001000011A (no)
HU (1) HUP0204422A3 (no)
IL (1) IL150541A0 (no)
IS (1) IS6442A (no)
MA (1) MA26867A1 (no)
MX (1) MXPA02007223A (no)
NO (1) NO20023526L (no)
NZ (1) NZ519550A (no)
OA (1) OA12166A (no)
PA (1) PA8510601A1 (no)
PE (1) PE20011064A1 (no)
PL (1) PL357076A1 (no)
SK (1) SK10622002A3 (no)
SV (1) SV2002000290A (no)
TN (1) TNSN01013A1 (no)
UY (1) UY26550A1 (no)
WO (1) WO2001055078A1 (no)
ZA (1) ZA200205880B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
EP1539127A1 (en) * 2002-08-22 2005-06-15 Warner-Lambert Company Llc Method of treating osteoarthritis
WO2006115130A1 (ja) * 2005-04-19 2006-11-02 Eisai R & D Management Co., Ltd. ビス［（２ｓ）－３－［３－［（２ｓ）－３－（４－クロロ－２－シアノフェノキシ）－２－フルオロプロポキシ］フェニル］－２－イソプロポキシプロピオン酸］カルシウム及びその中間体
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
CN111704543A (zh) * 2014-11-14 2020-09-25 燿石治疗公司 用于制备α,ω-二羧酸封端的二烷醚的方法和中间体
CN110996928A (zh) * 2017-04-18 2020-04-10 燿石治疗公司 吉卡宾、其药学上可接受的盐、其组合物和其使用方法
CN113396138A (zh) * 2018-10-18 2021-09-14 燿石治疗公司 吉卡宾、其药学上可接受的盐、其组合物和其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
CA2397960C (en) 2008-09-09
AP2002002587A0 (en) 2002-09-30
CN1395555A (zh) 2003-02-05
GT200100015A (es) 2001-10-19
CZ20022474A3 (cs) 2003-06-18
HN2001000011A (es) 2001-06-13
PE20011064A1 (es) 2001-10-22
DZ3239A1 (fr) 2001-08-02
BR0107763A (pt) 2002-11-12
DK1259474T3 (da) 2009-07-20
MXPA02007223A (es) 2002-11-29
WO2001055078A1 (en) 2001-08-02
IS6442A (is) 2002-06-25
HUP0204422A2 (en) 2003-05-28
ZA200205880B (en) 2003-07-23
ATE431326T1 (de) 2009-05-15
PL357076A1 (en) 2004-07-12
TNSN01013A1 (fr) 2005-11-10
EA004862B1 (ru) 2004-08-26
KR20020073182A (ko) 2002-09-19
CO5261537A1 (es) 2003-03-31
ES2324281T3 (es) 2009-08-04
BG106851A (en) 2003-01-31
IL150541A0 (en) 2003-02-12
PA8510601A1 (es) 2002-08-26
NZ519550A (en) 2003-11-28
UY26550A1 (es) 2001-08-27
EP1259474A1 (en) 2002-11-27
GEP20053428B (en) 2005-01-25
JP2003520835A (ja) 2003-07-08
EP1259474B1 (en) 2009-05-13
AR029436A1 (es) 2003-06-25
DE60138686D1 (de) 2009-06-25
OA12166A (en) 2003-11-07
EA200200641A1 (ru) 2002-12-26
JP4750995B2 (ja) 2011-08-17
EE200200404A (et) 2003-10-15
CA2397960A1 (en) 2001-08-02
SV2002000290A (es) 2002-07-16
NO20023526D0 (no) 2002-07-24
MA26867A1 (fr) 2004-12-20
SK10622002A3 (sk) 2003-07-01
AU2214001A (en) 2001-08-07
HUP0204422A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
BRPI0307673A2 (pt) métodos de tratar doença vascular.
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
EA200701175A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
NO20014769L (no) Preparat for behandling og diagnostikk av brystcancer og fremgangsmater for anvendelse derav
CY1112184T1 (el) Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii
IS2641B (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE50211137D1 (de) Seitenkettenhalogenierte aminodicarbonsaurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
DE50201780D1 (de) Halogensubstituierte aminodicarbonsäurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20023526L (no) Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes
NO20020156L (no) Titanavledede forbindelser, fremstilling og anvendelse derav
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
DE60220220D1 (de) Blutbehandlungssystem
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
DE60105053D1 (de) Zusammensetzungen zur behandlung von gewebe
ATE353693T1 (de) Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application